ES2108261T3 - Derivados 2-aminoazucar de macrolidos. - Google Patents

Derivados 2-aminoazucar de macrolidos.

Info

Publication number
ES2108261T3
ES2108261T3 ES93903554T ES93903554T ES2108261T3 ES 2108261 T3 ES2108261 T3 ES 2108261T3 ES 93903554 T ES93903554 T ES 93903554T ES 93903554 T ES93903554 T ES 93903554T ES 2108261 T3 ES2108261 T3 ES 2108261T3
Authority
ES
Spain
Prior art keywords
pct
macrolides
azucar
derivatives
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93903554T
Other languages
English (en)
Inventor
Kevin Koch
Gary R Schulte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2108261T3 publication Critical patent/ES2108261T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Abstract

LOS MACROLIDOS DE LA FORMULA (I) Y LOS METODOS DE TRATAMIENTO DE RESISTENCIA A LOS TRANSPLANTES, INFECCIONES DE HONGOS Y ENFERMEDADES AUTOINMUNES TALES COMO ARTRITIS REUMATOIDE Y PSORIASIS QUE USAN DICHOS MACROLIDOS DE LA FORMULA (I), EN DONDE N ES 1 O 2; A Y B VAN JUNTOS Y FORMAN =O O A Y B VAN SEPARADAMENTE Y SON CADA UNO H O A ES OH Y B ES H; R1 ES UN GRUPO 2-AMINOGLICOSIL; R2 ES OH O UN GRUPO GLICOSILOXI; Y R3 ES UN GRUPO ALQUILO O ALILO.
ES93903554T 1992-03-02 1993-01-27 Derivados 2-aminoazucar de macrolidos. Expired - Lifetime ES2108261T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84433992A 1992-03-02 1992-03-02

Publications (1)

Publication Number Publication Date
ES2108261T3 true ES2108261T3 (es) 1997-12-16

Family

ID=25292446

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93903554T Expired - Lifetime ES2108261T3 (es) 1992-03-02 1993-01-27 Derivados 2-aminoazucar de macrolidos.

Country Status (11)

Country Link
US (1) US5631235A (es)
EP (1) EP0636136B1 (es)
JP (1) JP2562001B2 (es)
AT (1) ATE159725T1 (es)
CA (1) CA2131373C (es)
DE (1) DE69314947T2 (es)
DK (1) DK0636136T3 (es)
ES (1) ES2108261T3 (es)
FI (1) FI107537B (es)
GR (1) GR3025672T3 (es)
WO (1) WO1993018048A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP584198A0 (en) * 1998-09-14 1998-10-08 Fujisawa Pharmaceutical Co., Ltd. New use
US7160867B2 (en) 2003-05-16 2007-01-09 Isotechnika, Inc. Rapamycin carbohydrate derivatives
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
AU6286690A (en) * 1989-08-18 1991-04-03 Fisons Plc Macrocyclic compounds
DE69021833T2 (de) * 1989-11-09 1996-03-21 Sandoz Ag Heteroatome enthaltende tricyclische Verbindungen.
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
EP0466365A3 (en) * 1990-07-03 1992-04-15 Merck & Co. Inc. Novel immunosuppressant fermentation products of a microorganism

Also Published As

Publication number Publication date
US5631235A (en) 1997-05-20
FI944015A0 (fi) 1994-09-01
JPH07500350A (ja) 1995-01-12
FI944015A (fi) 1994-09-01
DE69314947T2 (de) 1998-03-05
ATE159725T1 (de) 1997-11-15
EP0636136B1 (en) 1997-10-29
WO1993018048A1 (en) 1993-09-16
JP2562001B2 (ja) 1996-12-11
GR3025672T3 (en) 1998-03-31
FI107537B (fi) 2001-08-31
DE69314947D1 (de) 1997-12-04
CA2131373A1 (en) 1993-09-16
CA2131373C (en) 1999-01-26
EP0636136A1 (en) 1995-02-01
DK0636136T3 (da) 1997-12-22

Similar Documents

Publication Publication Date Title
ES2154270T3 (es) Nuevos derivados del imidazol, su preparacion y sus aplicaciones terapeuticas.
PT839154E (pt) Peptidos e composicoes biologicamente activos sua utilizacao
ES2065880T3 (es) Proteina quimicamente modificada y obtencion de la misma.
FI943805A (fi) Substituoituja adeniinijohdannaisten käyttö multippeliskleroosin hoitoon
ES2125233T3 (es) Tratamiento de las infecciones retrovirales humanas con 2',3'-didesoxiinosina.
MY109002A (en) Amino-substituted pyrrazoles.
DE69838172D1 (de) Oxindolylchinazolinderivate als angiogenesehemmer
NO945034L (no) Derivater i vitamin D-serien modifisert ved 20-stilling, en fremg. for frems. av slike derivater, mellomprodukter anvendt ved fremg., farmasöytiske preparater inneholdende derivatene og deres anvendelse ved frems. av legemidler
ES2160593T3 (es) Desosamino-derivados de microlidos como inmunosupresores y agentes antifungicos.
EP0074268A3 (en) Improvements in or relating to thieno and furopyridinium-substituted cephalosporin derivatives
ATE34985T1 (de) 1,7-diamino-1,4-dihydro-4-oxo-3-(aza) chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung bakterieller erkrankungen.
CA2132457A1 (en) Fluorosugar Derivatives of Macrolides
EP0774462A4 (en) HETEROCYCLIC COMPOUND
ES2108261T3 (es) Derivados 2-aminoazucar de macrolidos.
ATE48421T1 (de) Hustenstillende und schleimregulierende 2substituierte thiazole.
ES8703456A1 (es) Procedimiento para preparar derivados de nitrofurano
GR3023757T3 (en) Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents.
KR880007494A (ko) 5-아릴-3h-1,2,4-트리아졸-3-온 및 진경제로서의 그들의 용도
DE69416311D1 (de) Verwendung von cephem-derivaten als antimetastatische mittel
ES2106567T3 (es) 3-aril-4-alquil y 4,5-dialquil-4h-1,2,4-triazoles utiles como mejoradores de la memoria.
CA2131372A1 (en) Sugar Derivatives of Macrolides
ES2111330T3 (es) Derivados de 5-(1-fluor-vinil)-1h-pirimidina-2,4-diona que son utiles como agentes neoplasicos.
ES8107249A1 (es) Un procedimiento para la preparacion de derivados de 2-epi- fortimicina.
ATE165089T1 (de) Thiocarbamoylverbindungen als mikrobizide
DE69409799T2 (de) Herstellung von symmetrischen und unsymmetrischen disubstituierten n-cyandithioiminocarbonaten

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 636136

Country of ref document: ES